Shedding light on neurofilament involvement in cognitive decline in obstructive sleep apnea and its possible role as a biomarker
Open Access
- 30 November 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14, 1289367
Abstract
Obstructive sleep apnea is one of the most common sleep disorders with a high estimated global prevalence and a large number of associated comorbidities in general as well as specific neuropsychiatric complications such as cognitive impairment. The complex pathogenesis and effects of the disorder including chronic intermittent hypoxia and sleep fragmentation may lead to enhanced neuronal damage, thereby contributing to neuropsychiatric pathologies. Obstructive sleep apnea has been described as an independent risk factor for several neurodegenerative diseases, including Alzheimer's disease and all-cause dementia. The influence of obstructive sleep apnea on cognitive deficits is still a topic of recent debate, and several mechanisms, including neurodegeneration and depression-related cognitive dysfunction, underlying this correlation are taken into consideration. The differentiation between both pathomechanisms of cognitive impairment in obstructive sleep apnea is a complex clinical issue, requiring the use of multiple and costly diagnostic methods. The studies conducted on neuroprotection biomarkers, such as brain-derived neurotrophic factors and neurofilaments, are recently gaining ground in the topic of cognition assessment in obstructive sleep apnea patients. Neurofilaments as neuron-specific cytoskeletal proteins could be useful non-invasive indicators of brain conditions and neurodegeneration, which already are observed in many neurological diseases leading to cognitive deficits. Additionally, neurofilaments play an important role as a biomarker in other sleep disorders such as insomnia. Thus, this review summarizes the current knowledge on the involvement of neurofilaments in cognitive decline and neurodegeneration in obstructive sleep apnea patients as well as discusses its possible role as a biomarker of these changes.Keywords
This publication has 103 references indexed in Scilit:
- The Effects of CPAP Treatment on Task Positive and Default Mode Networks in Obstructive Sleep Apnea Patients: An fMRI StudyPLOS ONE, 2012
- Magnetic Resonance Spectroscopy and Neurocognitive Dysfunction in Obstructive Sleep Apnea before and after CPAP TreatmentSLEEP, 2012
- Mouse intermittent hypoxia mimicking apnoea of prematurity: effects on myelinogenesis and axonal maturationThe Journal of Pathology, 2011
- The role of serotonin in respiratory function and dysfunctionRespiratory Physiology & Neurobiology, 2010
- Dysregulation of Insulin Signaling, Glucose Transporters, O-GlcNAcylation, and Phosphorylation of Tau and Neurofilaments in the BrainThe American Journal of Pathology, 2009
- Small heat shock proteins Hsp27 or αB‐crystallin and the protein components of neurofibrillary tangles: Tau and neurofilamentsJournal of Neuroscience Research, 2007
- Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebellaMolecular and Cellular Neuroscience, 2007
- Chronic intermittent but not constant hypoxia decreases NAA/Cr ratios in neonatal mouse hippocampus and thalamusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Neurofilament Polymer Transport in AxonsJournal of Neuroscience, 2005
- Changes in brain morphology associated with obstructive sleep apneaSleep Medicine, 2003